Benefits: Protects the body from harmful free radicals
Foundayo is expected around late 2026 or early 2027
Summary: There is no established causal link between Mounjaro (tirzepatide) and diverticulitis based on current clinical trial data and post-marketing surveillance
TB-500 TB-500 is a synthetic peptide fragment designed to mimic the active region of Thymosin Beta-4, but with greater stability and shelf life, making it more practical for research storage and use
It primarily arises from the catabolism of nutritional substrates such as phosphatidylcholine, choline, carnitine, betaine, dimethylglycine, and ergothioneine by the colonic microbiota (118)
Now, it is also FDA-approved to help with weight loss in adults with a BMI greater than or equal to 30 mg/kg alone or 27 mg/kg with at least one weight-related comorbidity such as insulin resistance, hypertension, high cholesterol, heart disease, and gout